tebentafuspafamitresgene autoleucelDARKFOX-A3solid tumorsesophageal adenocarcinomaTargeted immunotherapiesovarian carcinomas
…gy for solid tumors, exemplified by the recent FDA approvals of tebentafusp and afamitresgene autoleucel, which target Class I peptide-HLA …